Medivation, Inc. leads Monday small-cap pre-market volume
Medivation, Inc. (Nasdaq: MDVN) announced its Alzheimer’s drug Dimebon significantly improved symptoms over one year and was more effective than a placebo used in a clinical trial.
Neurochem Inc. (Nasdaq: NRMX) reported some positive preliminary data in a Phase III trial of its Alzheimer’s drug tramiprosate, but the Canadian company said it is still working on analysis. Neurochem said it will announce top-line trial results during the second quarter ending June 30.
Private equity group BBAC LLC announced it is taking Back Yard Burgers, Inc. (Nasdaq: BYBI) private for approximately $38 million.
The following are the most actively traded companies in Monday pre-market trading among those with market capitalizations under $500 million:
| Price at | % | ||||||
| 9:15 et | Change | Change | Volume | Year High | Year Low |
